Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 14, 2020

SELL
$10.34 - $15.51 $21,724 - $32,586
-2,101 Closed
0 $0
Q1 2020

May 15, 2020

SELL
$9.11 - $20.05 $13,428 - $29,553
-1,474 Reduced 41.23%
2,101 $27,000
Q4 2019

Feb 14, 2020

BUY
$18.47 - $24.03 $66,030 - $85,907
3,575 New
3,575 $73,000
Q3 2018

Nov 13, 2018

SELL
$13.1 - $16.35 $93,874 - $117,164
-7,166 Closed
0 $0
Q2 2018

Aug 13, 2018

BUY
$13.65 - $18.7 $97,815 - $134,004
7,166 New
7,166 $104,000

Others Institutions Holding LNTH

About Lantheus Holdings, Inc.


  • Ticker LNTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 68,741,904
  • Market Cap $7.1B
  • Description
  • Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...
More about LNTH
Track This Portfolio

Track Itau Unibanco Holding S.A. Portfolio

Follow Itau Unibanco Holding S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Itau Unibanco Holding S.A., based on Form 13F filings with the SEC.

News

Stay updated on Itau Unibanco Holding S.A. with notifications on news.